Veracyte (VCYT) Income from Continuing Operations (2012 - 2026)

Veracyte has reported Income from Continuing Operations for 15 years, with the latest figure at 25490000.0 in Q2 2026.

• Income from Continuing Operations for Q2 2026 came in at 25490000.0, up 2701.02% year-over-year; the trailing twelve-month figure through Jun 2026 was 114487000.0 (up 334.77% YoY), and the FY2025 annual result was 66353000.0, up 174.89% from the prior year.
• Income from Continuing Operations retreated to 25490000.0 in Q2 2026, from 28674000.0 in the prior quarter.
• Over five years, Income from Continuing Operations peaked at 41186000.0 in Q4 2025 and troughed at 29572000.0 in Q3 2023.
• A 5-year average of 1877222.22 and a median of 1422000.0 in 2024 frame the typical range for Income from Continuing Operations.
• The widest annual swing landed in 2023, when Income from Continuing Operations plunged 630.33%; it then surged 2701.02% in 2026.
• A 5-year view of Income from Continuing Operations shows it stood at 3874000.0 in 2022, then plunged by 630.33% to 28293000.0 in 2023, then jumped by 118.16% to 5137000.0 in 2024, then jumped by 701.75% to 41186000.0 in 2025, then tumbled by 38.11% to 25490000.0 in 2026.
• Per Business Quant data, the three most recent Income from Continuing Operations figures were 25490000.0 in Q2 2026, 28674000.0 in Q1 2026, and 41186000.0 in Q4 2025.